Duchenne muscular dystrophy drug

Search documents
Capricor Therapeutics shares tumble as FDA rejects Duchenne muscular dystrophy drug application
Proactiveinvestors NAยท 2025-07-11 15:17
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...